Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 04, 2016 08:00 ET | Source: Foamix, Ltd.

Foamix to Present Corporate Overview at the 3rd Annual Dermatology Summit Meeting

REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
December 03, 2015 07:00 ET | Source: Foamix, Ltd.

Foamix Announces Positive Top-Line Results From Phase II Study for FDX104 (Doxycycline Foam) in the Prevention of Acneiform Rash Associated With Targeted Antibody Treatments for Colon and Head and Neck Cancers

FDX104 prevented the development of moderate-to-severe antibody-induced rash in the majority of cases. FDX104 appears safe and was well-tolerated. REHOVOT, Israel and BRIDGEWATER, N.J.,...
December 02, 2015 16:01 ET | Source: Foamix, Ltd.

Foamix to Host Conference Call & Webcast to Discuss Topline Results From Phase 2 Study of FDX-104 in Acneiform Rash Associated With Targeted Antibody Treatments for Colon and Head and Neck Cancers

REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing...
December 01, 2015 08:00 ET | Source: Foamix, Ltd.

Foamix to Present Corporate Overview at the Oppenheimer 26th Annual Healthcare Conference

REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused...
November 11, 2015 08:00 ET | Source: Foamix, Ltd.

Foamix to Present Corporate Overview at Jefferies Autumn 2015 Global Healthcare Conference in London

REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
November 11, 2015 07:00 ET | Source: Foamix, Ltd.

Foamix Reports Third Quarter 2015 Financial Results and Provides Business Update

REHOVOT, Israel, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and...
October 27, 2015 13:00 ET | Source: Foamix, Ltd.

Foamix Pharmaceuticals Third Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, November 11

REHOVOT, Israel, and BRIDGEWATER, N.J., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
October 20, 2015 08:00 ET | Source: Foamix, Ltd.

Foamix Announces Enrollment of First Patient in Phase 2 Clinical Trial of FMX103 in Papulopustular Rosacea

REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
August 19, 2015 16:01 ET | Source: Foamix, Ltd.

Foamix Reports Second Quarter 2015 Financial Results and Provides Business Update

REHOVOT, Israel, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and...
August 13, 2015 08:00 ET | Source: Foamix, Ltd.

Foamix Pharmaceuticals Second Quarter 2015 Conference Call & Webcast Scheduled for Thursday, August 20

REHOVOT, Israel and BRIDGEWATER, N.J., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right